Forgot Password

Thank you for your request!

We will soon reach out to you.

Thank you for downloading..!

Contact us for more information.
Home » Healthcare » Pharmaceuticals » HPH-1601015
  • Global Ophthalmology Drug & Devices Market insights, Opportunities, Analysis, Market Shares and Forecast 2016 – 2022

  • Publish: January 2016 | Report Code: HPH-1601015

Ophthalmic drugs are the ointments which treat eye related disorders and are nonirritant. The global ophthalmic drug market is expected to grow at 6.9% by 2022. This industry is dominated by a bunch of companies having high growth potentials. In the recent years, due to the impact of generic prostaglandin analogues, the ophthalmic drugs market has been transformed.

The rising eye related disorders in the world, changing lifestyle, and rising healthcare expenditure are the major driving factors in the growth of the global ophthalmic drug market. Also, due to the growth in healthcare services, the life expectancy rate has also increased, which in turn is increasing the number of elderly or geriatric population worldwide. This elderly population is more likely to suffer from eyesight disorders like presbyopia, diabetic retinopathy, and muscular degeneration. With the upcoming sophisticated technology, people now to correct their eye related disorders are increasingly opting for ophthalmic surgeries.

The major types of ophthalmic drugs available in the global market are the prescription drugs and the Over the counter (OTC) drugs. OTC drugs are for ocular allergy and dry eyes and can be given without the need of prescription. On the basis of treatment, ophthalmic drugs are segmented as retinal drugs, Anti-glaucoma drugs, and Anti-inflammatory/ infective drugs, which are given on the basis of diagnosed condition. The anti-glaucoma drug acquires the largest market share in the global ophthalmic treatment drugs market. The ocular anesthetics are the drugs that are used by surgeons during a surgery.

The major constraints of the global ophthalmic drug market are the lack of awareness among the people related to eye disorders in the underdeveloped and developing countries, patent expiry of various blockbuster drugs, and the absence of health insurance is affecting the market adversely.

The global ophthalmic drug market is dominated by North America (US) due to increased initiatives to reduce blindness, as well as other related disorders amongst the geriatric population, followed by Europe (Germany, UK, and France), Asia Pacific and LAMEA.  Asia Pacific is expected to be one of the fastest growing markets for ophthalmic drugs in the world during the forecasted period, as the elderly population is more prone to suffer from eye related disorders due to age. Southeast Asian nations like India and China are the major consumers of the ophthalmic drugs which provide growth to the global ophthalmic drug market.

The key market players of the industry are continuously investing in research and development, for product launch with new combinations of therapies, and mergers and acquisitions.

Market leader in the ophthalmic drug market is Novartis, holding 24%of the total market share. Major players of the global ophthalmic drug market are Pfizer, Allergan, Santen, Roche, Bayer, Merck and Co., Valeant, Regeneron, and Senju.

1.       Introduction
1.1.    Executive summary
1.2.    Estimation methodology

2.       Market overview
2.1.    Market definition and scope
2.2.    Key findings
2.3.    Parametric analysis
2.3.1. Prevalence & incidence rate of eye disorders
2.3.2. Hospital and eye clinic across geographies
2.3.3. Increasing cataract surgeries
2.3.4. Healthcare expenditure across geographies
2.3.5. Disposable income of top emerging economies
2.4.     Key market insights
2.4.1.  Top 3 emerging countries
2.4.2. Top 3 revenue generating segments
2.4.3. Top growing markets and emerging trends
2.4.4. Pipeline analysis
2.4.4.1.  SHP616:acute neuromyelitis optica
2.4.4.2.  SHP622: friedreich’s ataxia
2.4.4.3.   SHP606: dry eye disease
2.4.4.4.   Lifitegrast: dry eye disease
2.4.4.5.   SHP626: non alcoholic steatohepatitis
2.4.4.6.   SHP627: focal segmental glomerulosclerosis
2.4.4.7.   Guanfacine: (EU) ADHD
2.4.4.8.   MIM-D3: dry eye disease
2.4.4.9.   EGP-437: dry eye disease
2.4.4.10.  EBI-005: dry eye disease
2.4.4.11.  RU-101: dry eye disease
2.4.4.12.  OTX-DP: dry eye disease
2.4.5. R&D scenario in ophthalmology market
2.4.5.1.    Plasma technology in ophthalmology
2.4.5.2.    Cornial topography & cornial analysis
2.4.5.3.    Scope of virtual reality technology in eye care
2.5.    Competitive intelligence
2.5.1. Market share analysis
2.5.2. Top winning strategies
2.5.3. Case studies: top competitive moves
2.6.    Value chain analysis
2.7.    Key buying criteria
2.8.    Strategic recommendation
2.9.    Strategic conclusions

3.       Market determinants
3.1.    Market drivers
3.1.1.  FDA approvals giving rise to adoption of drugs and devices
3.1.2.  Global increase in elderly population giving rise to ophthalmology market
3.1.3.  Technological advancement
3.1.4. Innovation giving rise to ophthalmology drug and device market
3.1.5.  Global increase in prevalence rates of eye diseases
3.1.6.  Global increase in adoption of ophthalmology therapies and drugs
3.1.7.  Global increase in healthcare expenditure
3.1.8.  Global increase in minimally invasive surgeries
3.1.9. High prevalence rates of refractive errors driving the surgeries in ophthalmology market
3.2.    Market restraints
3.2.1.   Major drugs going off patent is affecting the growth of ophthalmology market
3.2.2.  Drying pipelines is a concern for major players
3.3.    Market challenges
3.3.1. Risk associated with the ocular diseases
3.3.2.  Creating awareness for ophthalmology drug and device market
3.3.3. Global economic slowdown may affect the ophthalmology drug and device market
3.4.    Market opportunities
3.4.1. Intraocular lenses, phacoemulsification devices and increasing cataract surgeries to create opportunities in emerging economies
3.4.2.  Untapped APAC region has huge scope for ophthalmology drug and device market
3.4.3. Increase in diabetic retinopathies rising the demand for vitreoretinal surgeries

4.       Sector Analysis
4.1.    Parent market
4.2.    Sub-segment market
4.3.    Alternative market

5.       Top ophthalmic drugs brands
5.1.    Lucentis
5.2.    Eylea
5.3.    Avastin
5.4.    Restasis
5.5.    Lumigan and Ganfort
5.6.    Xalatan/Xalacom
5.7.    Travatan/Travatan Z and DuoTrav
5.8.    Alphagan/Alphagan P and Combigan
5.9.    Vigamox
5.10.  Pataday
5.11.  Refresh brand products
5.12.  Tapros
5.13.  Cosopt

6.      Market Segmentation
6.1.  Global ophthalmology device market
6.1.1. Global ophthalmic diagnostic & monitoring equipment market, 2014-2022,($ millions)
6.1.1.1.  Global optical coherence tomography scanners market, 2014-2022,($ millions)
6.1.1.2.  Global  ophthalmic ultra sound  imaging systems market, 2014-2022,($ millions)
6.1.1.3.  Global fundus camera market, 2014-2022,($ millions)
6.1.1.4.  Global  ophthal moscopes, 2014-2022,($ millions)
6.1.1.5.  Global  retinoscope market , 2014-2022,($ millions)
6.1.1.6.  Global pachymeter market, 2014-2022,($ millions)
6.1.1.7.  Global  wavefront aberrometers market , 2014-2022,($ millions)
6.1.1.8.  Global  perimeters/visual field analyzer market s, 2014-2022,($ millions)
6.1.1.9.  Global autorefractors/phoropter market, 2014-2022,($ millions)
6.1.1.10. Global keratometers, 2014-2022 market,($ millions)
6.1.1.11. Global  specular microscope market, 2014-2022,($ millions)
6.1.1.12. Global  corneal topoghaphers market, 2014-2022,($ millions)
6.1.1.13. Global  tonometers market, 2014-2022,($ millions)
6.1.1.14. Global  slit lamps market , 2014-2022,($ millions)
6.1.1.15. Global bio meters market, 2014-2022,($ millions)
6.1.1.16. Global other market, 2014-2022,($ millions)
6.1.2.  Global ophthalmology surgery device market , 2014-2022,($ millions)
6.1.2.1.   Global  cataract surgery device market , 2014-2022,($ millions)
6.1.2.1.1. Global  intraocular lens market, 2014-2022,($ millions)
6.1.2.1.2. Global  phacoemulsification devices market, 2014-2022,($ millions)
6.1.2.1.3. Global  ophthalmic Viscoelastic devices market, 2014-2022,($ millions)
6.1.2.2. Global glaucoma surgery device market, 2014-2022,($ millions)
6.1.2.2.1. Global stents and implant market, 2014-2022,($ millions)
6.1.2.2.2. Global  glaucoma drainage device market, 2014-2022,($ millions)
6.1.2.2.3. Global glaucoma system market, 2014-2022,($ millions)
6.1.2.2.4. Global glaucoma laser market , 2014-2022,($ millions)
6.1.2.3.              Global refractive surgery device market, 2014-2022,($ millions)
6.1.2.3.1.Global excimer laser market, 2014-2022,($ millions)
6.1.2.3.2.Global emcrokeratome market, 2014-2022,($ millions)
6.1.2.3.3.Global femtosecond laser market, 2014-2022,($ millions)
6.1.2.3.4.Global yag laser market, 2014-2022,($ millions)
6.1.2.4.              Global vitreoretinal surgery device market , 2014-2022,($ millions)
6.1.2.4.1.Global photocoagulation laser market, 2014-2022,($ millions)
6.1.2.4.2. Global  illumination device market, 2014-2022,($ millions)
6.1.2.4.3. Global vitrectomy machine market, 2014-2022,($ millions)
6.1.2.5.               Global visioncare market , 2014-2022,($ millions)
6.1.2.5.1.  Global contact lens market  , 2014-2022,($ millions)
6.1.2.5.2.  Global spectacles market, 2014-2022,($ millions)
6.2.  Global ophthalmology drug market , 2014-2022,($ millions)
6.2.1. Global drug delivery types , 2014-2022,($ millions)
6.2.1.1.   Global eye drops market , 2014-2022,($ millions)
6.2.1.2.  Global capsules & tablet market, 2014-2022,($ millions)
6.2.1.3.  Global eye ointment market, 2014-2022,($ millions)
6.2.1.4.  Global gel market , 2014-2022,($ millions)
6.2.1.5.   Global eye solution market , 2014-2022,($ millions)
6.2.2.  Glaucoma
6.2.2.1.   Xalatan (Latanoprost)/Xalacom (Latanoprost and Timolol combination) (Xalabrands)   
6.2.2.2.   Lumigan franchise [Lumigan (Bimatoprost) + Ganfort (Bimatoprost and Timolol combination)]   
6.2.2.3.   Tapros/Taflotan (Tafluprost)   
6.2.2.4.   Saflutan/Zioptan (Tafluprost)   
6.2.2.5.    Alphagan (Brimonidine)/Combigan (Brimonidine and Timolol combination)   
6.2.2.6.   Cosopt (Dorzolamide and Timolol combination)/ Trusopt (Dorzolamide)   
6.2.2.7.    Azarga (Brinzolamide and Timolol combination)   
6.2.2.8.    Azopt (Brinzolamide)
6.2.3. Global retinal disorder market , 2014-2022,($ millions)
6.2.3.1.   Lucentis (Ranibizumab)   
6.2.3.2.   Visudyne (Verteporfin)   
6.2.3.3.    Avastin (Bevacizumab)   
6.2.3.4.    Eylea (Aflibercept)   
6.2.4.     Dry eye
6.2.4.1.  Restasis (Cyclosporine)   
6.2.4.2.   Hyalein (Sodium hyaluronate)
6.2.4.3.    Diquas (Diquafosol sodium)
6.2.5.     Allergic conjunctivitis, inflammation and conjunctivitis
6.2.5.1.   Patanol/Pataday/Opatanol (Olopatadine)   
6.2.5.2.   Bepreve (Bepotastine besilate)   
6.2.5.3.   TobraDex (Tobramycin & Dexamethasone combination)   
6.2.5.4.   Xibrom/Bromday (Bromfenac)   
6.2.5.5.   Vigamox (Moxifloxacin)   
6.2.5.6.   AzaSite (Azithromycin)
6.3.  Global ophthalmology  drug and device market by therapeutics , 2014-2022,($ millions)
6.3.1. Global diabetic macular edema market, 2014-2022,($ millions)
6.3.2. Global eye cancer market, 2014-2022,($ millions)
6.3.3. Global diabetic retinopathy market, 2014-2022,($ millions)
6.3.4. Global retinal vein occlusion market, 2014-2022,($ millions)
6.3.5. Global age-related macular degeneration market, 2014-2022,($ millions)
6.3.6. Global conjunctivitis market, 2014-2022,($ millions)
6.3.7. Global dry eye market, 2014-2022,($ millions)
6.3.8. Global glaucoma market, 2014-2022,($ millions)
6.3.9. Global keratitis market, 2014-2022,($ millions)
6.3.10.    Global lens opacification and intraocular lens market, 2014-2022,($ millions)
6.3.11.    Global geographic atrophy market, 2014-2022,($ millions)
6.4.  Global ophthalmology drug and device market by end user, 2014-2022,($ millions)
6.4.1. Hospitals
6.4.2. Eye clinics
6.4.3. Diagnostic centers
6.4.4. Patients

7.       Competitive Landscape
7.1.    Market share
7.2.    Strategy – An analysis across tiers

8.       Geographical Analysis
8.1.    North America
8.1.1.  United States (U.S.)
8.1.2. Canada
8.2.    Europe
8.2.1. United Kingdom (UK)
8.2.2. France
8.2.3. Germany
8.2.4. Spain
8.2.5. Italy
8.2.6. RoE
8.3.    Asia Pacific
8.3.1. India
8.3.2. China
8.3.3. Japan
8.3.4. Korea
8.3.5. Australia
8.3.6. RoAPAC
8.4.    Rest of the world
8.4.1. Latin America
8.4.2. MENA
8.4.3. Africa

9.       Company Profiling: - (Over, SCOT analysis, strategic review)
9.1.    Abbot Laboratories
9.2.    Alcon  Inc
9.3.    Ellex Medical lasers ltd
9.4.    Essilor international S.A.
9.5.    Allergan Inc
9.6.    Bausch & Lomb Inc
9.7.    Carl Zeiss Meditec  AG
9.8.    Johnson and Johnson
9.9.    Hoya corporation
9.10.   Pfizer Inc
9.11.   Roche holding AG
9.12.   Santen pharmaceutical co. ltd
9.13.   Staar surgical company
9.14.   Iridex corporation
9.15.   Merc & Co. Inc
9.16.   Nidek Co. Ltd
9.17.   Topcon corporation
9.18.   Novagali Pharma S.A.
9.19.   Novartis AG
9.20.   Nicox
9.21.   Acucela
9.22.   Senju
9.23.   Bayer
9.24.    Valeant
9.25.     Regeneron
9.26.     Akorn
9.27.     Eyemed
9.28.     Visioncare ophthalmic technologies
9.29.     Biotech Visioncare
9.30.     VSP

List of Tables

1. Global ophthalmology device market, 2014-2022,($ millions)
2. Global ophthalmic diagnostic & monitoring equipment market, 2014-2022,($ millions)
3. Global optical coherence tomography scanners market, 2014-2022,($ millions)
4. Global ophthalmic ultra sound imaging systems market, 2014-2022,($ millions)
5. Global fundus camera market, 2014-2022,($ millions)
6. Global ophthalmoscopes, 2014-2022,($ millions)
7. Global retinoscope market , 2014-2022,($ millions)
8. Global pachymeter market, 2014-2022,($ millions)
9. Global wavefront aberrometers market , 2014-2022,($ millions)
10. Global perimeters/visual field analyzer market s, 2014-2022,($ millions)
11. Global autorefractors/phoropter market, 2014-2022,($ millions)
12. Global keratometers, 2014-2022 market,($ millions)
13. Global specular microscope market, 2014-2022,($ millions)
14. Global corneal topoghaphers market, 2014-2022,($ millions)
15. Global tonometers market, 2014-2022,($ millions)
16. Global slit lamps market , 2014-2022,($ millions)
17. Global bio meters market, 2014-2022,($ millions)
18. Global other market, 2014-2022,($ millions)
19. Global ophthalmology surgery device market , 2014-2022,($ millions)
20. Global cataract surgery device market , 2014-2022,($ millions)
21. Global intraocular lens market, 2014-2022,($ millions)
22. Global phacoemulsification devices market, 2014-2022,($ millions)
23. Global ophthalmic Viscoelastic devices market, 2014-2022,($ millions)
24. Global glaucoma surgery device market, 2014-2022,($ millions)
25. Global stents and implant market, 2014-2022,($ millions)
26. Global glaucoma drainage device market, 2014-2022,($ millions)
27. Global glaucoma system market, 2014-2022,($ millions)
28. Global glaucoma laser market , 2014-2022,($ millions)
29. Global refractive surgery device market, 2014-2022,($ millions)
30. Global excimer laser market, 2014-2022,($ millions)
31. Global emcrokeratome market, 2014-2022,($ millions)
32. Global femtosecond laser market, 2014-2022,($ millions)
33. Global yag laser market, 2014-2022,($ millions)
34. Global vitreoretinal surgery device market , 2014-2022,($ millions)
35. Global photocoagulation laser market, 2014-2022,($ millions)
36. Global illumination device market, 2014-2022,($ millions)
37. Global vitrectomy machine market, 2014-2022,($ millions)
38. Global visioncare market , 2014-2022,($ millions)
39. Global contact lens market , 2014-2022,($ millions)
40. Global spectacles market, 2014-2022,($ millions)
41. Global ophthalmology drug and device market by therapeutics , 2014-2022,($ millions)
42. Global diabetic macular edema market, 2014-2022,($ millions)
43. Global eye cancer market, 2014-2022,($ millions)
44. Global diabetic retinopathy market, 2014-2022,($ millions)
45. Global retinal vein occlusion market, 2014-2022,($ millions)
46. Global age-related macular degeneration market, 2014-2022,($ millions)
47. Global conjunctivitis market, 2014-2022,($ millions)
48. Global dry eye market, 2014-2022,($ millions)
49. Global glaucoma market, 2014-2022,($ millions)
50. Global keratitis market, 2014-2022,($ millions)
51. Global lens opacification and intraocular lens market, 2014-2022,($ millions)
52. Global geographic atrophy market, 2014-2022,($ millions)
53. Global ophthalmology drug market, 2014-2022, ($ millions)
54. Global drug delivery types, 2014-2022, ($ millions)
55. Global eye drops market, 2014-2022, ($ millions)
56. Global capsules & tablet market, 2014-2022, ($ millions)
57. Global eye ointment market, 2014-2022, ($ millions)
58. Global gel market, 2014-2022, ($ millions)
59. Global eye solution market, 2014-2022, ($ millions)
60. Global retinal disorder market, 2014-2022, ($ millions)
61. Global ophthalmology drug and device market by end user, 2014-2022, ($ millions)
62. Global ophthalmology market by hospitals, 2014-2022, ($ millions)
63. Global ophthalmology market by eye clinics, 2014-2022, ($ millions)
64. Global ophthalmology market by diagnostic centers, 2014-2022, ($ millions)
65. Global ophthalmology market by patients, 2014-2022, ($ millions)

FAQ

How can I purchase a report?
We offer an easy way to purchase any report of your choice from various domains that we offer. You can easily search for your desired reports by simply using the search bar on our website's home page. For multiple purchases, you can add reports to the shopping cart, fill a detail form and check out. We accept payments though authentic and trusted payment gateways which accept all major credit cards.
How safe is to use my credit card? Is my information secure?
We ensure complete safety to all online transactions made by credit cards. We use most secure encryption technology available today for the electronic transactions and all our credit card sales are secured with an SSL technology. Your information is highly secure and confidential.
Can I get a discount?
We send discount offers through email as per your request. In case you would like to receive discounts, please sign up for our newsletter.
I want to buy only a chapter. I don't need complete report.
Yes you can buy your desired chapter/page or the entire report, by just clicking on the table of contents in any report and selecting chapter of your interest. We do have separate pricing for chapters/reports/excel sheets/presentation pages etc.
Can I get reports on my desired topic specially which is not available in your current portfolio?
Do call us or mail us the topic of your preference. Our dedicated team on analysts will prepare a report as per your preference and requirements.
When do I get access to the report(s) that I have purchased?
We will email you your purchased report right after we receive your payment through any of the payment options.
Will I receive any invoice for my purchase?
Yes we will email you invoice/payment confirmation with the order details once we receive your payment.
In what format will the reports be available in?
All the reports will be available in PDF format for download.

Request for Sample/TOC

credit card

CONNECT WITH US

Occams Business Research & Consulting Pvt. Ltd.

Landline: 0731 4042636 

Handheld: +91 8966901752

Email: sales@occamsresearch.com

 

 

Go To Top
viewthroughconversion